Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

NKTR holding history

Nektar Therapeutics in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings

Shares (Q2 2025)
0
Sold out in Q2 2025
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q1 2021
Holdings of NKTR by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20250$00.0%−7,679−100.0%Sold outConverted for a 1-for-15 splitHolders
Q1 2025115,190$78.3K<0.1%−60,003−34.2%ReducedHolders
Q4 2024175,193$162.9K<0.1%+127,459+267.0%AddedHolders
Q3 202447,734$62.1K<0.1%−298,916−86.2%ReducedHolders
Q2 2024346,650$429.8K<0.1%−2,202,340−86.4%ReducedHolders
Q1 20242,548,990$2.38M<0.1%−1,549,854−37.8%ReducedHolders
Q4 20234,098,844$2.32M<0.1%−2,024,180−33.1%ReducedHolders
Q3 20236,123,024$3.65M<0.1%−3,029,297−33.1%ReducedHolders
Q2 20239,152,321$5.26M<0.1%+5,850,660+177.2%AddedHolders
Q1 20233,301,661$2.32M<0.1%+2,173,745+192.7%AddedHolders
Q4 20221,127,916$2.55M<0.1%+448,995+66.1%AddedHolders
Q3 2022678,921$2.17M<0.1%+127,965+23.2%AddedHolders
Q2 2022550,956$2.09M<0.1%−90,662−14.1%ReducedHolders
Q1 2022641,618$3.46M<0.1%+254,385+65.7%AddedHolders
Q4 2021387,233$5.23M<0.1%−28,166−6.8%ReducedHolders
Q3 2021415,399$7.46M<0.1%+89,514+27.5%AddedHolders
Q2 2021325,885$5.59M<0.1%−89,026−21.5%ReducedHolders
Q1 2021414,911$8.30M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.